1	GDP	GDP	B-NP	NN	O	4	NMOD	-1
2	and	and	I-NP	CC	O	4	NMOD	-1
3	AGE	AGE	I-NP	NN	O	4	NMOD	-1
4	receptors	receptor	I-NP	NNS	O	6	NMOD	-1
5	:	:	O	:	O	4	P	-1
6	mechanisms	mechanism	B-NP	NNS	O	0	ROOT	-1
7	of	of	B-PP	IN	O	6	NMOD	-1
8	peritoneal	peritoneal	B-NP	JJ	O	9	NMOD	-1
9	damage	damage	I-NP	NN	O	7	PMOD	6	damage
10	.	.	O	.	O	6	P	-1

1	Long-term	Long-term	B-NP	JJ	O	3	NMOD	-1
2	peritoneal	peritoneal	I-NP	JJ	O	3	NMOD	-1
3	dialysis	dialysis	I-NP	NN	O	7	SUB	-1
4	(	(	O	(	O	6	DEP	-1
5	PD	PD	B-NP	NN	O	6	DEP	-1
6	)	)	O	)	O	3	NMOD	-1
7	is	be	B-VP	VBZ	O	0	ROOT	-1
8	limited	limit	I-VP	VBN	O	7	VC	0
9	by	by	B-PP	IN	O	8	VMOD	-1
10	morphological	morphological	B-NP	JJ	O	11	NMOD	-1
11	changes	change	I-NP	NNS	O	9	PMOD	0
12	of	of	B-PP	IN	O	11	NMOD	-1
13	the	the	B-NP	DT	O	15	NMOD	-1
14	peritoneal	peritoneal	I-NP	JJ	O	15	NMOD	-1
15	membrane	membrane	I-NP	NN	O	12	PMOD	-1
16	.	.	O	.	O	7	P	-1

1	Structural	Structural	B-NP	JJ	O	2	NMOD	-1
2	changes	change	I-NP	NNS	O	3	SUB	0
3	were	be	B-VP	VBD	O	0	ROOT	-1
4	promoted	promote	I-VP	VBN	O	3	VC	17	promoted
5	by	by	B-PP	IN	O	4	VMOD	-1
6	toxicity	toxicity	B-NP	NN	O	5	PMOD	-1
7	of	of	B-PP	IN	O	6	NMOD	-1
8	glucose	glucose	B-NP	NN	B-protein	10	NMOD	-1
9	degradation	degradation	I-NP	NN	I-protein	10	NMOD	0
10	products	product	I-NP	NNS	I-protein	7	PMOD	-1
11	(	(	O	(	O	13	DEP	-1
12	GDPs	GDP	B-NP	NNS	B-protein	13	DEP	-1
13	)	)	O	)	O	10	NMOD	-1
14	which	which	B-NP	WDT	O	10	NMOD	-1
15	are	be	B-VP	VBP	O	14	SBAR	-1
16	generated	generate	I-VP	VBN	O	15	VC	-1
17	during	during	B-PP	IN	O	16	VMOD	-1
18	heat	heat	B-NP	NN	O	19	NMOD	-1
19	sterilization	sterilization	I-NP	NN	O	17	PMOD	-1
20	in	in	B-PP	IN	O	19	NMOD	-1
21	peritoneal	peritoneal	B-NP	JJ	O	23	NMOD	-1
22	dialysis	dialysis	I-NP	NN	O	23	NMOD	-1
23	fluids	fluid	I-NP	NNS	O	20	PMOD	-1
24	(	(	O	(	O	26	DEP	-1
25	PDFs	PDF	B-NP	NNS	B-protein	26	DEP	-1
26	)	)	O	)	O	23	NMOD	-1
27	.	.	O	.	O	3	P	-1

1	Besides	Besides	B-PP	IN	O	6	VMOD	-1
2	their	their	B-NP	PRP$	O	5	NMOD	-1
3	direct	direct	I-NP	JJ	O	5	NMOD	-1
4	toxicity	toxicity	I-NP	NN	O	5	NMOD	-1
5	GDPs	GDP	I-NP	NNS	O	6	SUB	-1
6	promote	promote	B-VP	VBP	O	0	ROOT	17	promote
7	formation	formation	B-NP	NN	O	6	OBJ	8	formation
8	of	of	B-PP	IN	O	7	NMOD	-1
9	advanced	advance	B-NP	VBN	O	11	NMOD	-1
10	glycation	glycation	I-NP	NN	B-protein	11	NMOD	-1
11	endproducts	endproduct	I-NP	NNS	I-protein	8	PMOD	-1
12	(	(	O	(	O	14	DEP	-1
13	AGEs	AGE	B-NP	NNS	O	14	DEP	-1
14	)	)	O	)	O	11	NMOD	-1
15	.	.	O	.	O	6	P	-1

1	RAGE	RAGE	B-NP	NN	O	7	SUB	-1
2	(	(	O	(	O	6	DEP	-1
3	receptor	receptor	B-NP	NN	O	6	DEP	-1
4	for	for	B-PP	IN	O	3	NMOD	-1
5	AGE	AGE	B-NP	NN	O	4	PMOD	-1
6	)	)	O	)	O	1	NMOD	-1
7	is	be	B-VP	VBZ	O	0	ROOT	-1
8	the	the	B-NP	DT	O	13	NMOD	-1
9	best	good	I-NP	JJS	O	10	AMOD	-1
10	characterized	characterize	I-NP	VBN	O	13	NMOD	-1
11	signal	signal	I-NP	NN	B-protein	13	NMOD	-1
12	transduction	transduction	I-NP	NN	I-protein	13	NMOD	-1
13	receptor	receptor	I-NP	NN	I-protein	7	PRD	-1
14	for	for	B-PP	IN	O	13	NMOD	-1
15	AGEs	AGE	B-NP	NNS	O	14	PMOD	-1
16	and	and	O	CC	O	7	VMOD	-1
17	is	be	B-VP	VBZ	O	7	VMOD	-1
18	expressed	express	I-VP	VBN	O	17	VC	9	expressed
19	on	on	B-PP	IN	O	18	VMOD	-1
20	mesothelial	mesothelial	B-NP	JJ	B-cell_type	21	NMOD	-1
21	cells	cell	I-NP	NNS	I-cell_type	19	PMOD	-1
22	.	.	O	.	O	7	P	-1

1	The	The	B-NP	DT	O	2	NMOD	-1
2	effects	effect	I-NP	NNS	O	10	SUB	0
3	of	of	B-PP	IN	O	2	NMOD	-1
4	PDFs	PDF	B-NP	NNS	B-protein	3	PMOD	-1
5	with	with	B-PP	IN	O	2	NMOD	-1
6	different	different	B-NP	JJ	O	7	NMOD	-1
7	amounts	amount	I-NP	NNS	O	5	PMOD	-1
8	of	of	B-PP	IN	O	7	NMOD	-1
9	GDPs	GDP	B-NP	NNS	B-protein	8	PMOD	-1
10	were	be	B-VP	VBD	O	0	ROOT	-1
11	compared	compare	I-VP	VBN	O	10	VC	-1
12	on	on	B-PP	IN	O	11	VMOD	-1
13	morphological	morphological	B-NP	JJ	O	14	NMOD	-1
14	changes	change	I-NP	NNS	O	12	PMOD	0
15	in	in	B-PP	IN	O	14	NMOD	-1
16	the	the	B-NP	DT	O	18	NMOD	-1
17	peritoneal	peritoneal	I-NP	JJ	O	18	NMOD	-1
18	membrane	membrane	I-NP	NN	O	15	PMOD	-1
19	in	in	B-PP	IN	O	14	NMOD	-1
20	a	a	B-NP	DT	O	24	NMOD	-1
21	RAGE	RAGE	I-NP	NN	O	24	NMOD	-1
22	-/-	-/-	I-NP	JJ	O	24	NMOD	-1
23	mouse	mouse	I-NP	NN	O	24	NMOD	-1
24	model	model	I-NP	NN	O	19	PMOD	-1
25	.	.	O	.	O	10	P	-1

1	It	It	B-NP	PRP	O	2	SUB	-1
2	could	could	B-VP	MD	O	0	ROOT	-1
3	be	be	I-VP	VB	O	2	VC	-1
4	demonstrated	demonstrate	I-VP	VBN	O	3	VC	-1
5	that	that	B-SBAR	IN	O	4	VMOD	-1
6	RAGE	RAGE	B-NP	NN	B-protein	7	SUB	-1
7	plays	play	B-VP	VBZ	O	5	SBAR	-1
8	a	a	B-NP	DT	O	10	NMOD	-1
9	pivotal	pivotal	I-NP	JJ	O	10	NMOD	-1
10	role	role	I-NP	NN	O	7	OBJ	0
11	in	in	B-PP	IN	O	7	VMOD	-1
12	structural	structural	B-NP	JJ	O	13	NMOD	-1
13	damage	damage	I-NP	NN	O	11	PMOD	0
14	(	(	O	(	O	21	DEP	-1
15	e.g.	e.g.	B-NP	FW	O	21	DEP	-1
16	inflammation	inflammation	I-NP	NN	O	20	NMOD	-1
17	,	,	O	,	O	20	P	-1
18	neoangiogenesis	neoangiogenesis	B-NP	NN	O	20	NMOD	3	neoangiogenesis
19	and	and	O	CC	O	20	NMOD	-1
20	fibrosis	fibrosis	B-NP	NN	O	21	DEP	-1
21	)	)	O	)	O	13	NMOD	-1
22	of	of	B-PP	IN	O	13	NMOD	-1
23	the	the	B-NP	DT	O	25	NMOD	-1
24	peritoneal	peritoneal	I-NP	JJ	O	25	NMOD	-1
25	membrane	membrane	I-NP	NN	O	22	PMOD	-1
26	.	.	O	.	O	2	P	-1

1	Further	Further	B-NP	JJ	O	2	NMOD	-1
2	investigations	investigation	I-NP	NNS	O	12	SUB	-1
3	of	of	B-PP	IN	O	2	NMOD	-1
4	this	this	B-NP	DT	O	5	NMOD	-1
5	pathway	pathway	I-NP	NN	O	3	PMOD	0
6	with	with	B-PP	IN	O	2	NMOD	-1
7	regard	regard	B-NP	NN	O	6	PMOD	-1
8	to	to	B-PP	TO	O	7	NMOD	-1
9	preventing	prevent	B-VP	VBG	O	8	PMOD	0
10	peritoneal	peritoneal	B-NP	JJ	O	11	NMOD	-1
11	fibrosis	fibrosis	I-NP	NN	O	9	OBJ	-1
12	should	should	B-VP	MD	O	0	ROOT	-1
13	be	be	I-VP	VB	O	12	VC	-1
14	performed	perform	I-VP	VBN	O	13	VC	-1
15	to	to	B-VP	TO	O	16	VMOD	-1
16	maintain	maintain	I-VP	VB	O	14	VMOD	-1
17	the	the	B-NP	DT	O	18	NMOD	-1
18	integrity	integrity	I-NP	NN	O	16	OBJ	-1
19	of	of	B-PP	IN	O	18	NMOD	-1
20	the	the	B-NP	DT	O	22	NMOD	-1
21	peritoneal	peritoneal	I-NP	JJ	O	22	NMOD	-1
22	membrane	membrane	I-NP	NN	O	19	PMOD	-1
23	in	in	B-PP	IN	O	18	NMOD	-1
24	peritoneal	peritoneal	B-NP	JJ	O	26	NMOD	-1
25	dialysis	dialysis	I-NP	NN	O	26	NMOD	-1
26	patients	patient	I-NP	NNS	O	23	PMOD	-1
27	.	.	O	.	O	12	P	-1

